Index Entries

Mina Psichogiou, Michael Samarkos, Nikolaos Mikos, and Angelos Hatzakis
June 1, 2021
Vaccines
National and Kapodistrian University of Athens (Greece)

Abstract: Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.”

document
adverse events,COVID-19,shingles (herpes zoster) and chickenpox (herpes varicella),vaccines